Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

A New Conjugation Method Used for the Development of an Immunoassay for the Detection of Amanitin, a Deadly Mushroom Toxin.

Bever CS, Barnych B, Hnasko R, Cheng LW, Stanker LH.

Toxins (Basel). 2018 Jun 28;10(7). pii: E265. doi: 10.3390/toxins10070265.

2.

Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling.

Rock KS, Ndeffo-Mbah ML, Castaño S, Palmer C, Pandey A, Atkins KE, Ndung'u JM, Hollingsworth TD, Galvani A, Bever C, Chitnis N, Keeling MJ.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S286-S292. doi: 10.1093/cid/ciy018.

3.

A subset of mobilized human hematopoietic stem cells express germ layer lineage genes which can be modulated by culture conditions.

Makar T, Nimmagadda VK, Guda PR, Hampton B, Huang W, Kane MA, Fishman PS, Pessac B, Bever CT Jr, Trisler D.

Stem Cell Res Ther. 2018 May 2;9(1):127. doi: 10.1186/s13287-018-0858-5.

4.

Effects of triclosan in breast milk on the infant fecal microbiome.

Bever CS, Rand AA, Nording M, Taft D, Kalanetra KM, Mills DA, Breck MA, Smilowitz JT, German JB, Hammock BD.

Chemosphere. 2018 Jul;203:467-473. doi: 10.1016/j.chemosphere.2018.03.186. Epub 2018 Mar 28.

PMID:
29635158
5.

A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits.

Hugos CL, Chen Z, Chen Y, Turner AP, Haselkorn J, Chiara T, McCoy S, Bever CT Jr, Cameron MH, Bourdette D; VA MS Fatigue Study Group.

Mult Scler. 2017 Dec 1:1352458517745723. doi: 10.1177/1352458517745723. [Epub ahead of print]

PMID:
29226778
6.

Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.

Gerzanich V, Makar TK, Guda PR, Kwon MS, Stokum JA, Woo SK, Ivanova S, Ivanov A, Mehta RI, Morris AB, Bryan J, Bever CT, Simard JM.

J Neuroinflammation. 2017 Sep 2;14(1):177. doi: 10.1186/s12974-017-0953-z.

7.

Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study.

Gerardin J, Bever CA, Bridenbecker D, Hamainza B, Silumbe K, Miller JM, Eisele TP, Eckhoff PA, Wenger EA.

Malar J. 2017 Jun 12;16(1):248. doi: 10.1186/s12936-017-1903-z.

8.

Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.

Haselkorn JK, Hughes C, Rae-Grant A, Jung Henson L, Bever CT, Lo AC, Brown TR, Kraft GH, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurol Clin Pract. 2017 Jun;7(3):189-190. doi: 10.1212/01.CPJ.0000520916.56328.f5. No abstract available.

9.

Nanobody Based Immunoassay for Human Soluble Epoxide Hydrolase Detection Using Polymeric Horseradish Peroxidase (PolyHRP) for Signal Enhancement: The Rediscovery of PolyHRP?

Li D, Cui Y, Morisseau C, Gee SJ, Bever CS, Liu X, Wu J, Hammock BD, Ying Y.

Anal Chem. 2017 Jun 6;89(11):6248-6256. doi: 10.1021/acs.analchem.7b01247. Epub 2017 May 10.

10.

SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.

Hewes D, Tatomir A, Kruszewski AM, Rao G, Tegla CA, Ciriello J, Nguyen V, Royal W 3rd, Bever C, Rus V, Rus H.

Exp Mol Pathol. 2017 Apr;102(2):191-197. doi: 10.1016/j.yexmp.2017.01.014. Epub 2017 Jan 19.

PMID:
28109694
11.

Incidence and admission rates for severe malaria and their impact on mortality in Africa.

Camponovo F, Bever CA, Galactionova K, Smith T, Penny MA.

Malar J. 2017 Jan 3;16(1):1. doi: 10.1186/s12936-016-1650-6.

12.

Malaria Elimination Campaigns in the Lake Kariba Region of Zambia: A Spatial Dynamical Model.

Nikolov M, Bever CA, Upfill-Brown A, Hamainza B, Miller JM, Eckhoff PA, Wenger EA, Gerardin J.

PLoS Comput Biol. 2016 Nov 23;12(11):e1005192. doi: 10.1371/journal.pcbi.1005192. eCollection 2016 Nov.

13.

Introducing the Axon Registry: An opportunity to improve quality of neurologic care.

Sigsbee B, Goldenberg JN, Bever CT Jr, Schierman B, Jones LK Jr.

Neurology. 2016 Nov 22;87(21):2254-2258. Epub 2016 Sep 30.

PMID:
27694258
14.

Author Response.

Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. No abstract available.

PMID:
27500299
15.

SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Nimmagadda VK, Makar TK, Chandrasekaran K, Sagi AR, Ray J, Russell JW, Bever CT Jr.

J Neuroimmunol. 2017 Mar 15;304:29-34. doi: 10.1016/j.jneuroim.2016.07.007. Epub 2016 Jul 17. Review.

16.

VHH antibodies: emerging reagents for the analysis of environmental chemicals.

Bever CS, Dong JX, Vasylieva N, Barnych B, Cui Y, Xu ZL, Hammock BD, Gee SJ.

Anal Bioanal Chem. 2016 Sep;408(22):5985-6002. doi: 10.1007/s00216-016-9585-x. Epub 2016 May 21. Review.

17.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

McDonnell GV, Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. doi: 10.1212/WNL.0000000000002578. No abstract available.

PMID:
27044615
18.

Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.

Bever CT Jr, Wallin MT.

Mult Scler. 2016 Mar;22(3):267-8. doi: 10.1177/1352458516632382. No abstract available.

PMID:
26951816
19.

TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.

Makar TK, Nimmagadda VK, Singh IS, Lam K, Mubariz F, Judge SI, Trisler D, Bever CT Jr.

J Neuroimmunol. 2016 Mar 15;292:9-20. doi: 10.1016/j.jneuroim.2016.01.002. Epub 2016 Jan 6.

PMID:
26943953
20.

Detection of the Antimicrobial Triclosan in Environmental Samples by Immunoassay.

Ahn KC, Ranganathan A, Bever CS, Hwang SH, Holland EB, Morisseau K, Pessah IN, Hammock BD, Gee SJ.

Environ Sci Technol. 2016 Apr 5;50(7):3754-61. doi: 10.1021/acs.est.5b05357. Epub 2016 Mar 18.

21.

Optimal Population-Level Infection Detection Strategies for Malaria Control and Elimination in a Spatial Model of Malaria Transmission.

Gerardin J, Bever CA, Hamainza B, Miller JM, Eckhoff PA, Wenger EA.

PLoS Comput Biol. 2016 Jan 14;12(1):e1004707. doi: 10.1371/journal.pcbi.1004707. eCollection 2016 Jan.

22.

A Clinically Relevant Method of Analyzing Continuous Change in Robotic Upper Extremity Chronic Stroke Rehabilitation.

Massie CL, Du Y, Conroy SS, Krebs HI, Wittenberg GF, Bever CT, Whitall J.

Neurorehabil Neural Repair. 2016 Sep;30(8):703-12. doi: 10.1177/1545968315620301. Epub 2015 Dec 14.

23.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Haselkorn JK, Hughes C, Rae-Grant A, Henson LJ, Bever CT, Lo AC, Brown TR, Kraft GH, Getchius T, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurology. 2015 Nov 24;85(21):1896-903. doi: 10.1212/WNL.0000000000002146. Review.

24.

Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.

Makar TK, Gerzanich V, Nimmagadda VK, Jain R, Lam K, Mubariz F, Trisler D, Ivanova S, Woo SK, Kwon MS, Bryan J, Bever CT, Simard JM.

J Neuroinflammation. 2015 Nov 18;12:210. doi: 10.1186/s12974-015-0432-3.

25.

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, White MT, Wenger EA, Van de Velde N, Pemberton-Ross P, Griffin JT, Smith TA, Eckhoff PA, Muhib F, Jit M, Ghani AC.

Lancet. 2016 Jan 23;387(10016):367-375. doi: 10.1016/S0140-6736(15)00725-4. Epub 2015 Nov 6.

26.

Method for Sorting and Pairwise Selection of Nanobodies for the Development of Highly Sensitive Sandwich Immunoassays.

Rossotti MA, Pirez M, Gonzalez-Techera A, Cui Y, Bever CS, Lee KS, Morisseau C, Leizagoyen C, Gee S, Hammock BD, González-Sapienza G.

Anal Chem. 2015 Dec 1;87(23):11907-14. doi: 10.1021/acs.analchem.5b03561. Epub 2015 Nov 18.

27.

Practice improvement requires more than guidelines and quality measures.

Sigsbee B, Bever CT Jr, Jones LK Jr.

Neurology. 2016 Jan 12;86(2):188-93. doi: 10.1212/WNL.0000000000002116. Epub 2015 Oct 30. Review.

PMID:
26519541
28.

Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment.

Penny MA, Maire N, Bever CA, Pemberton-Ross P, Briët OJ, Smith DL, Gething PW, Smith TA.

Malar J. 2015 Oct 5;14:384. doi: 10.1186/s12936-015-0864-3.

29.

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

Kruszewski AM, Rao G, Tatomir A, Hewes D, Tegla CA, Cudrici CD, Nguyen V, Royal W 3rd, Bever CT Jr, Rus V, Rus H.

Exp Mol Pathol. 2015 Dec;99(3):498-505. doi: 10.1016/j.yexmp.2015.09.007. Epub 2015 Sep 25.

PMID:
26407760
30.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Rae-Grant A, Bennett A, Sanders AE, Phipps M, Cheng E, Bever C.

Neurology. 2015 Nov 24;85(21):1904-8. doi: 10.1212/WNL.0000000000001965. Epub 2015 Sep 2. Review. No abstract available. Erratum in: Neurology. 2016 Apr 12;86(15):1465.

31.

The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.

Narayanaswami P, Gronseth G, Dubinsky R, Penfold-Murray R, Cox J, Bever C Jr, Martins Y, Rheaume C, Shouse D, Getchius TS.

J Med Internet Res. 2015 Aug 13;17(8):e193. doi: 10.2196/jmir.4414.

32.

From puddles to planet: modeling approaches to vector-borne diseases at varying resolution and scale.

Eckhoff PA, Bever CA, Gerardin J, Wenger EA, Smith DL.

Curr Opin Insect Sci. 2015 Aug;10:118-123. doi: 10.1016/j.cois.2015.05.002. Epub 2015 May 14. Review.

33.

VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.

Culpepper WJ, Wallin MT, Magder LS, Perencevich E, Royal W, Bradham DD, Cutter G, Bever CT.

J Rehabil Res Dev. 2015;52(3):263-72. doi: 10.1682/JRRD.2014.07.0172.

34.

Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso.

Ouédraogo AL, Gonçalves BP, Gnémé A, Wenger EA, Guelbeogo MW, Ouédraogo A, Gerardin J, Bever CA, Lyons H, Pitroipa X, Verhave JP, Eckhoff PA, Drakeley C, Sauerwein R, Luty AJ, Kouyaté B, Bousema T.

J Infect Dis. 2016 Jan 1;213(1):90-9. doi: 10.1093/infdis/jiv370. Epub 2015 Jul 3.

PMID:
26142435
35.

One-step immunoassay for tetrabromobisphenol a using a camelid single domain antibody-alkaline phosphatase fusion protein.

Wang J, Majkova Z, Bever CR, Yang J, Gee SJ, Li J, Xu T, Hammock BD.

Anal Chem. 2015;87(9):4741-8. doi: 10.1021/ac504735p. Epub 2015 Apr 22.

36.

Smartphone-interfaced lab-on-a-chip devices for field-deployable enzyme-linked immunosorbent assay.

Chen A, Wang R, Bever CR, Xing S, Hammock BD, Pan T.

Biomicrofluidics. 2014 Nov 5;8(6):064101. doi: 10.1063/1.4901348. eCollection 2014 Nov.

37.

Fun with maths: exploring implications of mathematical models for malaria eradication.

Eckhoff PA, Bever CA, Gerardin J, Wenger EA.

Malar J. 2014 Dec 11;13:486. doi: 10.1186/1475-2875-13-486.

38.

Quality measurement: It's here to stay.

Cheng EM, Sanders AE, Cohen AB, Bever CT Jr.

Neurol Clin Pract. 2014 Oct;4(5):441-446.

39.

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Wright S, Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M, Bourdette D, Gronseth GS, Narayanaswami P.

Neurology. 2014 Oct 14;83(16):1484-6. doi: 10.1212/01.wnl.0000455935.13606.91. No abstract available.

PMID:
25313380
40.

Heterologous antigen selection of camelid heavy chain single domain antibodies against tetrabromobisphenol A.

Wang J, Bever CR, Majkova Z, Dechant JE, Yang J, Gee SJ, Xu T, Hammock BD.

Anal Chem. 2014 Aug 19;86(16):8296-302. doi: 10.1021/ac5017437. Epub 2014 Aug 7.

41.

Impedance Biosensors: Applications to Sustainability and Remaining Technical Challenges.

Radhakrishnan R, Suni II, Bever CS, Hammock BD.

ACS Sustain Chem Eng. 2014 Jul 7;2(7):1649-1655. Epub 2014 Jun 10.

42.

Development and utilization of camelid VHH antibodies from alpaca for 2,2',4,4'-tetrabrominated diphenyl ether detection.

Bever CR, Majkova Z, Radhakrishnan R, Suni I, McCoy M, Wang Y, Dechant J, Gee S, Hammock BD.

Anal Chem. 2014 Aug 5;86(15):7875-82. doi: 10.1021/ac501807j. Epub 2014 Jul 9.

43.

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.

Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M, Bourdette D, Gronseth GS, Narayanaswami P.

Neurology. 2014 Mar 25;82(12):1083-92. doi: 10.1212/WNL.0000000000000250.

44.

Cell-based delivery of brain-derived neurotrophic factor in experimental allergic encephalomyelitis.

Makar TK, Nimmagadda VK, Trisler D, Bever CT Jr.

J Interferon Cytokine Res. 2014 Aug;34(8):641-7. doi: 10.1089/jir.2013.0160. Epub 2014 Mar 6. Review.

PMID:
24601738
45.

SIRT1 is decreased during relapses in patients with multiple sclerosis.

Tegla CA, Azimzadeh P, Andrian-Albescu M, Martin A, Cudrici CD, Trippe R 3rd, Sugarman A, Chen H, Boodhoo D, Vlaicu SI, Royal W 3rd, Bever C, Rus V, Rus H.

Exp Mol Pathol. 2014 Apr;96(2):139-48. doi: 10.1016/j.yexmp.2013.12.010. Epub 2014 Jan 5.

PMID:
24397908
46.

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, Bever C Jr, Schiffer RB, Gronseth GS, Narayanaswami P; Guideline Development Subcommittee of the American Academy of Neurology.

Neurology. 2014 Jan 14;82(2):174-81. doi: 10.1212/WNL.0000000000000013. Epub 2013 Dec 27.

47.

Isolation of alpaca anti-idiotypic heavy-chain single-domain antibody for the aflatoxin immunoassay.

Wang Y, Li P, Majkova Z, Bever CR, Kim HJ, Zhang Q, Dechant JE, Gee SJ, Hammock BD.

Anal Chem. 2013 Sep 3;85(17):8298-303. doi: 10.1021/ac4015885. Epub 2013 Aug 21.

48.

Quality measures for neurologists: Financial and practice implications.

Cohen AB, Sanders AE, Swain-Eng RJ, Gjorvad G, Tonn ST, Bever CT Jr, Cheng EM.

Neurol Clin Pract. 2013 Feb;3(1):44-51.

49.

Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Nimmagadda VK, Bever CT, Vattikunta NR, Talat S, Ahmad V, Nagalla NK, Trisler D, Judge SI, Royal W 3rd, Chandrasekaran K, Russell JW, Makar TK.

J Immunol. 2013 May 1;190(9):4595-607. doi: 10.4049/jimmunol.1202584. Epub 2013 Apr 1.

50.

Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.

Goolsby J, Makar T, Dhib-Jalbut S, Bever CT Jr, Pessac B, Trisler D.

J Neuroimmunol. 2013 Apr 15;257(1-2):13-20. doi: 10.1016/j.jneuroim.2013.01.004. Epub 2013 Feb 1.

PMID:
23375677

Supplemental Content

Support Center